drugset / Trial / NCT02278198

Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123

NCT02278198

Phase 1 Completed 5 enrolled University of Colorado, Denver
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of the study is to find out if the small dose of radioiodine, that is used for the dosimetry study on patients with differentiated thyroid cancer, may stun the cancer cells and make the thyroid cancer treatment less effective.

Timeline

Start
2012-11-30
Primary completion
2019-09-20
Completion
2019-09-20

Drugs

EvaluationDrugModalityDoseRoute
Background rhTSH Protein / enzyme biologic Intramuscular